Genomics is back on the list for Congress, with creating an additional new agency and a focus on collecting the necessary information to allow research and development. Also included would be guidelines and rules related to genetic and pharmacogenomic tests to bring both Pharma and medical...
Posted to
The Medical Quack .... by Barbara Duck
on 09-12-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Congress, Pharmacogenomics